References
- Rodríguez-calvo-de-mora M, Quilendrino R, Ham L, Liarakos VS, Van Dijk K, Baydoun L, Dapena I, Oellerich S, Melles GR. Two-year clinical outcome of 500 consecutive cases undergoing descemet membrane endothelial keratoplasty. Cornea. 2017;36(6):655–60. doi:https://doi.org/10.1097/ICO.0000000000001176.
- Claesson M, Armitage WJ, Stenevi U. Corneal oedema after cataract surgery: predisposing factors and corneal graft outcome. Acta Ophthalmol. 2009;87(2):154–59. doi:https://doi.org/10.1111/j.1755-3768.2008.01180.x.
- Yagi-Yaguchi Y, Yamaguchi T, Higa K, Suzuki T, Aketa N, Dogru M, Satake Y, Shimazaki J. Association between corneal endothelial cell densities and elevated cytokine levels in the aqueous humor. Sci Rep. 2017 Oct 19;7(1):13603. doi:https://doi.org/10.1038/s41598-017-14131-3.
- Dapena I, Ham L, Droutsas K, Van Dijk K, Moutsouris K, Melles GRJ. Learning curve in descemet’s membrane endothelial keratoplasty: first series of 135 consecutive cases. Ophthalmology. 2011;118(11):2147–54. doi:https://doi.org/10.1016/j.ophtha.2011.03.037.
- Guerra FP, Anshu A, Price MO, Giebel AW, Price FW. Descemet’s membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011 Dec 1;118(12):2368–73. doi:https://doi.org/10.1016/j.ophtha.2011.06.002.
- Anshu A, Price MO, Price FW. Risk of corneal transplant rejection significantly reduced with descemet’s membrane endothelial keratoplasty. Ophthalmology. 2012 Mar 1;119(3):536–40. doi:https://doi.org/10.1016/j.ophtha.2011.09.019.
- Feng MT, Price MO, Miller JM, Price FW. Air reinjection and endothelial cell density in descemet membrane endothelial keratoplasty: five-year follow-up. J Cataract Refract Surg. 2014 Jul 1;40(7):1116–21. doi:https://doi.org/10.1016/j.jcrs.2014.04.023.
- Van Dijk K, Ham L, Tse WH, Liarakos VS, Quilendrino R, Yeh RY, Melles GR. Near complete visual recovery and refractive stability in modern corneal transplantation: descemet membrane endothelial keratoplasty (DMEK). Contact Lens Anter Eye. 2013 Feb 1;36(1):13–21. doi:https://doi.org/10.1016/j.clae.2012.10.066.
- Feng MT, Burkhart ZN, Price FWJ, Price MO. Effect of donor preparation-to-use times on descemet membrane endothelial keratoplasty outcomes. Cornea. 2013;32(8):1080–82. doi:https://doi.org/10.1097/ICO.0b013e318292a7e5.
- Monnereau C, Quilendrino R, Dapena I, Liarakos VS, Alfonso JF, Arnalich-Montiel F, Böhnke M, Pereira NC, Dirisamer M, Parker J, et al. Multicenter study of descemet membrane endothelial keratoplasty: first case series of 18 surgeons. JAMA Ophthalmol. 2014;132(10):1192–98. doi:https://doi.org/10.1001/jamaophthalmol.2014.1710.
- Price MO, Price FWJ, Kruse FE, Bachmann BO, Tourtas T. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty. Cornea. 2014;33(9):880–86. doi:https://doi.org/10.1097/ICO.0000000000000206.
- Chaurasia S, Price FW, Gunderson L, Price MO. Descemet’s membrane endothelial keratoplasty: clinical results of single versus triple procedures (combined with cataract surgery). Ophthalmology. 2014 Feb 1;121(2):454–58. doi:https://doi.org/10.1016/j.ophtha.2013.09.032.
- Rodríguez-calvo-de-mora M, Quilendrino R, Ham L, Liarakos VS, Van Dijk K, Baydoun L, Dapena I, Oellerich S, Melles GR. Clinical outcome of 500 consecutive cases undergoing descemet’s membrane endothelial keratoplasty. Ophthalmology. 2015 Mar 1;122(3):464–70. doi:https://doi.org/10.1016/j.ophtha.2014.09.004.
- Hamzaoglu EC, Straiko MD, Mayko ZM, Sáles CS, Terry MA. The first 100 eyes of standardized descemet stripping automated endothelial keratoplasty versus standardized descemet membrane endothelial keratoplasty. Ophthalmology. 2015 Nov 1;122(11):2193–99. doi:https://doi.org/10.1016/j.ophtha.2015.07.003.
- Heinzelmann S, Maier P, Böhringer D, Hüther S, Eberwein P, Reinhard T. Cystoid macular oedema following descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2015;99(1):98. doi:https://doi.org/10.1136/bjophthalmol-2014-305124.
- Price MO, Scanameo A, Feng MT, Price FW. Descemet’s membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids. Ophthalmology. 2016 Jun 1;123(6):1232–36. doi:https://doi.org/10.1016/j.ophtha.2016.02.001.
- Price MO, Feng MT, Scanameo A, Price FWJ. Loteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after descemet membrane endothelial keratoplasty: prospective randomized trial. Cornea. 2015;34(8):853–58. doi:https://doi.org/10.1097/ICO.0000000000000475.
- Rock T, Bramkamp M, Bartz-Schmidt KU, Rock D, Yoruk E. Causes that influence the detachment rate after Descemet membrane endothelial keratoplasty. Graefe’s Arch Clin Exper Ophthalmol. 2015 Dec;253(12):2217–22. doi:https://doi.org/10.1007/s00417-015-3103-2.
- Maier AK, Gundlach E, Schroeter J, Klamann MK, Gonnermann J, Riechardt AI, Bertelmann E, Joussen AM, Torun N. Influence of the difficulty of graft unfolding and attachment on the outcome in descemet membrane endothelial keratoplasty. Graefe’s Arch Clin Exper Ophthalmol. 2015 Jun;253(6):895–900. doi:https://doi.org/10.1007/s00417-015-2939-9.
- Gorovoy IR, Gorovoy MS. Descemet membrane endothelial keratoplasty postoperative year 1 endothelial cell counts. Am J Ophthalmol. 2015;159(3):597–600.e2. doi:https://doi.org/10.1016/j.ajo.2014.12.008.
- Ham L, Dapena I, Liarakos VS, Baydoun L, Van Dijk K, Ilyas A, Oellerich S, Melles GR. Midterm results of descemet membrane endothelial keratoplasty: 4 to 7 years clinical outcome. Am J Ophthalmol. 2016 Nov 1;171:113–21. doi:https://doi.org/10.1016/j.ajo.2016.08.038.
- Schaub F, Enders P, Snijders K, Schrittenlocher S, Siebelmann S, Heindl LM, Bachmann BO, Cursiefen C. One-year outcome after descemet membrane endothelial keratoplasty (DMEK) comparing sulfur hexafluoride (SF6) 20% versus 100% air for anterior chamber tamponade. Br J Ophthalmol. 2017;101(7):902. doi:https://doi.org/10.1136/bjophthalmol-2016-309653.
- Heinzelmann S, Bohringer D, Eberwein P, Reinhard T, Maier P. Outcomes of descemet membrane endothelial keratoplasty, descemet stripping automated endothelial keratoplasty and penetrating keratoplasty from a single centre study. Graefe’s Arch Clin Exper Ophthalmol. 2016 Mar;254(3):515–22. doi:https://doi.org/10.1007/s00417-015-3248-z.
- Veldman PB, Dye PK, Holiman JD, Mayko ZM, Sáles CS, Straiko MD, Galloway JD, Terry MA. The S-stamp in descemet membrane endothelial keratoplasty safely eliminates upside-down graft implantation. Ophthalmology. 2016 Jan 1;123(1):161–64. doi:https://doi.org/10.1016/j.ophtha.2015.08.044.
- Siggel R, Adler W, Stanzel TP, Cursiefen C, Heindl LM. Bilateral descemet membrane endothelial keratoplasty: analysis of clinical outcome in first and fellow eye. Cornea. 2016;35(6):772–77. doi:https://doi.org/10.1097/ICO.0000000000000811.
- Debellemanière G, Guilbert E, Courtin R, Panthier C, Sabatier P, Gatinel D, Saad A. Impact of surgical learning curve in descemet membrane endothelial keratoplasty on visual acuity gain. Cornea. 2017;36(1):1–6. doi:https://doi.org/10.1097/ICO.0000000000001066.
- Phillips PM, Phillips LJ, Muthappan V, Maloney CM, Carver CN. Experienced DSAEK surgeon’s transition to DMEK: outcomes comparing the last 100 DSAEK surgeries with the first 100 DMEK surgeries exclusively using previously published techniques. Cornea. 2017 Mar;36(3):275–79. doi:https://doi.org/10.1097/ICO.0000000000001069.
- Hos D, Tuac O, Schaub F, Stanzel TP, Schrittenlocher S, Hellmich M, Bachmann BO, Cursiefen C. Incidence and clinical course of immune reactions after descemet membrane endothelial keratoplasty: retrospective analysis of 1000 consecutive eyes. Ophthalmology. 2017 Apr 1;124(4):512–18. doi:https://doi.org/10.1016/j.ophtha.2016.12.017.
- Newman LR, DeMill DL, Zeidenweber DA, Mayko ZM, Bauer AJ, Tran KD, Straiko MD, Terry MA. Preloaded descemet membrane endothelial keratoplasty donor tissue: surgical technique and early clinical results. Cornea. 2018;37(8):981–86. doi:https://doi.org/10.1097/ICO.0000000000001646.
- Brockmann T, Brockmann C, Maier A-KB, Schroeter J, Bertelmann E, Torun N. Primary descemet’s membrane endothelial keratoplasty for fuchs endothelial dystrophy versus bullous keratopathy: histopathology and clinical results. Curr Eye Res. 2018 Oct;43(10):1221–27. doi:https://doi.org/10.1080/02713683.2018.1490773.
- Janson BJ, Terveen DC, Benage MJ, Zimmerman MB, Mixon DC, Aldrich BT, Skeie JM, Schmidt GA, Reed CR, Goins KM, et al. DMEK outcomes using nondiabetic grafts for recipients with diabetes mellitus. Am J Ophthalmol Case Rep. 2019;15:100512–100512. doi:https://doi.org/10.1016/j.ajoc.2019.100512.
- Schrittenlocher S, Bachmann B, Cursiefen C. Impact of donor tissue diameter on postoperative central endothelial cell density in descemet membrane endothelial keratoplasty. Acta Ophthalmol. 2019;97(4):e618–22. doi:https://doi.org/10.1111/aos.13943.
- Santander-García D, Peraza-Nieves J, Müller TM, Gerber-Hollbach N, Baydoun L, Liarakos VS, Dapena I, Oellerich S, Van Dijk K, Melles GRJ. Influence of intraoperative air tamponade time on graft adherence in descemet membrane endothelial keratoplasty. Cornea. 2019;38(2):166–72. doi:https://doi.org/10.1097/ICO.0000000000001795.
- Rickmann A, Wahl S, Katsen-Globa A, Szurman P. Safety analysis and results of a borosilicate glass cartridge for no-touch graft loading and injection in descemet membrane endothelial keratoplasty. Int Ophthalmol. 2019 Oct;39(10):2295–301. doi:https://doi.org/10.1007/s10792-018-01067-4.
- Hill JR, Chen SY, Bauer AJ, Straiko MMW, Sanchez PJ, Straiko MD, Terry MA. Younger donor tissue in descemet membrane endothelial keratoplasty surgery: clinical outcomes. Cornea. 2020 Dec 2. doi:https://doi.org/10.1097/ICO.0000000000002582.
- Straiko MD, Bauer AJ, Straiko MMW, Potts LB, Chen SY, Tran KD, Terry MA. Donor DMEK tissue characteristics: association with rebubble rate and 6-month endothelial cell loss. Cornea. 2020 Oct;39(10):1267–73. doi:https://doi.org/10.1097/ICO.0000000000002398.
- Parker JS, Ham L, Parker CP, Parker JS, Dockery PW, Melles GRJ. DMEK in super-seniors: clinical outcomes of descemet membrane endothelial keratoplasty performed in patients ≥ 90 years old. Curr Eye Res. 2020;45(9):1031–35. doi:https://doi.org/10.1080/02713683.2020.1726407.
- Dapena I, Moutsouris K, Droutsas K, Ham L, Van Dijk K, Melles GR. Standardized “no-touch” technique for descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2011 Jan;129(1):88–94.
- Livny E, Bahar I, Levy I, Mimouni M, Nahum Y. “PI-less DMEK”: results of descemet’s membrane endothelial keratoplasty (DMEK) without a peripheral iridotomy. Eye (Lond). 2019 Apr;33(4):653–58. doi:https://doi.org/10.1038/s41433-018-0294-x.
- Smith SD. Statistical tools in the quest for truth: hypothesis testing, confidence intervals, and the power of clinical studies. Ophthalmology. 2008 Mar;115(3):423–24. doi:https://doi.org/10.1016/j.ophtha.2007.12.016.
- Deng SX, Lee WB, Hammersmith KM, Kuo AN, Li JY, Shen JF, Weikert MP, Shtein RM. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American academy of ophthalmology. Ophthalmology. 2018 Feb 1;125(2):295–310. doi:https://doi.org/10.1016/j.ophtha.2017.08.015.
- Duman F, Kosker M, Suri K, Reddy JC, Ma JF, Hammersmith KM, Nagra PK, Rapuano CJ. Indications and outcomes of corneal transplantation in geriatric patients. Am J Ophthalmol. 2013;156(3):600–607.e2. doi:https://doi.org/10.1016/j.ajo.2013.04.034.
- Maurino, V. and Aiello, F. “Glaucoma risks in advanced corneal surgery” Progress in brain research. 2015;221: 271–95.
- Broadway DC, Cate H. Pharmacotherapy and adherence issues in treating elderly patients with glaucoma. Drugs Aging. 2015 Jul 1;32(7):569–81. doi:https://doi.org/10.1007/s40266-015-0282-9.
- Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 1990;74(8):477–80. doi:https://doi.org/10.1136/bjo.74.8.477.
- Fujimoto H, Maeda N, Soma T, Oie Y, Koh S, Tsujikawa M, Nishida K. Quantitative regional differences in corneal endothelial abnormalities in the central and peripheral zones in Fuchs’ endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2014;55(8):5090–98. doi:https://doi.org/10.1167/iovs.14-14249.
- Huang MJ, Kane S, Dhaliwal DK. Descemetorhexis without endothelial keratoplasty versus DMEK for treatment of fuchs endothelial corneal dystrophy. Cornea. 2018;37(12):1479–83. doi:https://doi.org/10.1097/ICO.0000000000001742.
- Birbal RS, Baydoun L, Ham L, Miron A, Van Dijk K, Dapena I, Jager MJ, Böhringer S, Oellerich S, Melles GRJ. Effect of surgical indication and preoperative lens status on descemet membrane endothelial keratoplasty outcomes. Am J Ophthalmol. 2020;212:79–87. doi:https://doi.org/10.1016/j.ajo.2019.12.011.